Arachidonic Acid for Health & Longevity - Quick Reference Sheet
evipedia.ai ← Back

Arachidonic Acid for Health & Longevity

Created on 07/24/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 4.8 – Audit

An omega-6 fat the body makes and gets from meat, eggs, and poultry, sold to enhance strength and power from resistance training. The muscle benefit is plausible but unproven, resting on small, conflicting trials. Feared heart, stroke, and cancer harms are not borne out; risks are mostly theoretical, concentrating in people on blood thinners or with inflammatory conditions. (Full Review)

Protocol

Dose
1–1.5 g/day
Most commonly 1.5 g/day during an active training block
Timing
With meals
Split into 2–3 daily doses for a steadier supply and tolerability
Cycling
8-week blocks
Time-limited training aid, not continuous use; no taper needed
Time to effect
Strength & Power
~8 weeks
Training outcomes emerged over 8-week trials
Tissue Saturation
2–4 weeks
Blood and muscle phospholipids plateau
Washout
2–4 weeks
Levels decline toward baseline after stopping

Benefits

Contraindications
  • Bleeding disorders
  • Anticoagulant or antiplatelet therapy
  • Recent cardiovascular events (myocardial infarction within 90 days)
  • Active rheumatoid arthritis
  • Poorly controlled asthma
  • Pregnancy or breastfeeding
    •
Key Interactions
  • NSAIDs and aspirin (ibuprofen, naproxen)
  • Omega-3 supplements (fish oil, EPA/DHA)
  • Bleeding-risk supplement stack (high-dose fish oil, Ginkgo biloba, garlic extract, vitamin E)
  • Corticosteroids
    •

Risk & Side Effects

  • High:
  • Medium: Increased platelet aggregation & bleeding-related effects
    •
  • Low: Amplified acute inflammatory response; gastrointestinal discomfort
    •
  • Speculative: Cardiovascular & cerebrovascular risk; aggravation of pre-existing inflammatory conditions
    •

Monitoring

Marker Target Why
Omega-3 Index > 8% of red-cell fatty acids Confirms an adequate omega-3 counterbalance
AA:EPA ratio ~1.5–3 : 1 Gauges balance vs the main omega-3 competitor
hs-CRP < 1.0 mg/L Tracks low-grade inflammation supplementation could amplify
Platelet function / bleeding time Within laboratory reference Screens for excess clotting tendency
Fasting lipid panel LDL-C and triglycerides at individual targets Provides cardiovascular context

Cadence: Baseline, then at ~4 and 8–12 weeks into a cycle; every 6–12 months if use continues

Qualitative Assessment

  • Strength and power progression in training logs
  • Quality of recovery and any change in joint or muscle soreness
  • Energy and perceived training capacity
  • Any easy bruising, prolonged bleeding, or new digestive upset
Not medical advice. Educational distillation of a single evidence review. Confirm any decision with a qualified clinician, especially in the presence of prescription drugs or chronic conditions.